Literature DB >> 8439244

Advancing a neurodevelopmental origin for schizophrenia.

F E Bloom1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8439244     DOI： 10.1001/archpsyc.1993.01820150074008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  26 in total

Review 1.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

2.  Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.

Authors:  E A Thomas; B Dean; G Pavey; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 3.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

4.  AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.

Authors:  Mark D Black; Rachel J Stevens; Nancy Rogacki; Robert E Featherstone; Yaw Senyah; Odessa Giardino; Beth Borowsky; Jeanne Stemmelin; Caroline Cohen; Philippe Pichat; Michal Arad; Segev Barak; Amaya De Levie; Ina Weiner; Guy Griebel; Geoffrey B Varty
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

5.  Dopamine modulates cell cycle in the lateral ganglionic eminence.

Authors:  Nobuyo Ohtani; Tomohide Goto; Christian Waeber; Pradeep G Bhide
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

6.  Gαz regulates BDNF-induction of axon growth in cortical neurons.

Authors:  Rainbo Hultman; Udhaya Kumari; Nadine Michel; Patrick J Casey
Journal:  Mol Cell Neurosci       Date:  2013-12-07       Impact factor: 4.314

7.  Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing.

Authors:  Rajendra A Morey; Seniha Inan; Teresa V Mitchell; Diana O Perkins; Jeffrey A Lieberman; Aysenil Belger
Journal:  Arch Gen Psychiatry       Date:  2005-03

8.  Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains.

Authors:  D Barbeau; J J Liang; Y Robitalille; R Quirion; L K Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  No association between polymorphisms of WNT2 and schizophrenia in a Korean population.

Authors:  Hak-Jae Kim; Jin Kyung Park; Su Kang Kim; Sung Wook Kang; Jong Woo Kim; Hyun-Kyung Park; Ah-Rang Cho; Ji Young Song; Joo-Ho Chung
Journal:  BMC Med Genet       Date:  2010-05-24       Impact factor: 2.103

10.  Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat.

Authors:  Mark D Black; Geoffrey B Varty; Michal Arad; Segev Barak; Amaya De Levie; Denis Boulay; Philippe Pichat; Guy Griebel; Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.